TAMBOCOR Side Effects

6752740-7 | Heart Rate Irregular, Hypotension, Incorrect Dose Administered, Overdose, Supraventricular Tachycardia
on May 19, 2010 Female patient from UNITED STATES , weighting 5.51 lb, was diagnosed with heart rate irregular and was treated with Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate irregular, hypotension, incorrect dose administered, overdose, supraventricular tachycardia. Tambocor dosage: 4 Mg; Q8h; Po. Patient was hospitalized.

6717614-6 | Dyspnoea, Fatigue, Nausea, Product Quality Issue, Pulse Pressure Abnormal
Patient was taking Tambocor (View Usage). Patient had the following side effects: dyspnoea, fatigue, nausea (What is nausea?), product quality issue, pulse pressure abnormal on May 07, 2010 from UNITED STATES Additional patient health information: Female patient , 80 years of age, weighting 155.0 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Tambocor dosage: 3 Tabs Every 12 Hours Po. During the same period patient was treated with SECTRAL (View Sectral Review and Sectral Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), VITAMINS (View Vitamins Review and Vitamins Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), POTASSIUM (View Potassium Review and Potassium Label ).

6598853-4 | Anuria, Arrhythmia, Atrial Flutter, Bradycardia, Cardiac Failure, Loss Of Consciousness, Metabolic Acidosis, Renal Failure Acute, Therapeutic Agent Toxicity
Adverse event was reported on Feb 08, 2010 by a Male patient taking Tambocor (View Usage) (Dosage: ) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: NETHERLANDS , 48 years of age, After Tambocor was administered, patient had the following side effects: anuria, arrhythmia (What is arrhythmia?), atrial flutter, bradycardia, cardiac failure, loss of consciousness, metabolic acidosis, renal failure acute, therapeutic agent toxicity. During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

6596309-6 | Abdominal Discomfort, Aphonia, Asthenia, Cardiovascular Disorder, Deafness Unilateral, Depression, Fatigue, Gastric Disorder
on Feb 03, 2010 Female patient from UNITED STATES , weighting 180.0 lb, was diagnosed with arrhythmia (What is arrhythmia?) and was treated with Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, aphonia, asthenia, cardiovascular disorder, deafness unilateral, depression (What is depression?), fatigue, gastric disorder. Tambocor dosage: 100 Mg; Qd. During the same period patient was treated with FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.


6549045-6 | Arrhythmia, Benign Prostatic Hyperplasia, Bradycardia, Constipation, Gastrointestinal Stromal Tumour, Hypertension, Loss Of Consciousness, Metastases To Peritoneum, Neutrophil Count Decreased
on Sep 09, 2009 Male patient from JAPAN , weighting 123.5 lb, was diagnosed with gastrointestinal stromal tumour and was treated with Tambocor (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), benign prostatic hyperplasia, bradycardia, constipation (What is constipation?), gastrointestinal stromal tumour, hypertension, loss of consciousness, metastases to peritoneum, neutrophil count decreased. Tambocor dosage: ; Po. During the same period patient was treated with SUTENT (50 Mg; Qd;, 37.5 Mg; Qd) (View Sutent Review and Sutent Label ), GLEEVEC (View Gleevec Review and Gleevec Label ), EURAX H (View Eurax H Review and Eurax H Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ), ROPION (View Ropion Review and Ropion Label ). Patient was hospitalized.

6338472-8 | Accidental Overdose, Blood Alkaline Phosphatase Increased, Blood Glucose Decreased, Bradycardia, Bundle Branch Block, Bundle Branch Block Left, Cardiac Disorder, Cardio-respiratory Arrest, Convulsion
Patient was taking Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: accidental overdose, blood alkaline phosphatase increased, blood glucose decreased, bradycardia, bundle branch block, bundle branch block left, cardiac disorder, cardio-respiratory arrest, convulsion on Aug 17, 2009 from CANADA Additional patient health information: Male patient , weighting 28.00 lb, was diagnosed with nodal arrhythmia and. Tambocor dosage: 100 Mg - Once - Oral. During the same period patient was treated with NADOLOL (View Nadolol Review and Nadolol Label ). Patient was hospitalized.

5933750-6 | Caesarean Section
Adverse event was reported on Oct 13, 2008 by a Female patient taking Tambocor (View Usage) (Dosage: 300 Mg - Qd - Maternal Oral Dose) was diagnosed with tachycardia foetal and. Location: GERMANY , weighting 4.45 lb, Patient experienced the following unwanted or unexpected effects: caesarean section.

5897572-7 | Neuropathy Peripheral
on May 22, 2008 Female patient from UNITED STATES , weighting 112.0 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). Patient had the following side effects: neuropathy peripheral. Tambocor dosage: Oral. During the same period patient was treated with LANOXIN (View Lanoxin Review and Lanoxin Label ), METOPROLOL (TOPROL) (View Metoprolol (toprol) Review and Metoprolol (toprol) Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), CALTRATE (View Caltrate Review and Caltrate Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), FLAXSEED OIL (View Flaxseed Oil Review and Flaxseed Oil Label ).

5755965-2 | Deafness Unilateral
on May 14, 2008 Female patient from CANADA , 57 years of age, was diagnosed with heart rate irregular and was treated with Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: deafness unilateral. Tambocor dosage: 50mg - Bid- Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), BISOPROLOL (MONOCOR) (View Bisoprolol (monocor) Review and Bisoprolol (monocor) Label ), HALOBETASOL PROPIONATE CREAM (ULTRAVATE) (View Halobetasol Propionate Cream (ultravate) Review and Halobetasol Propionate Cream (ultravate) Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CALCIUM SUPPLEMENT (View Calcium Supplement Review and Calcium Supplement Label ).

5743824-0 | Atrial Fibrillation, Contraindication To Medical Treatment, Ischaemic Cardiomyopathy, Ventricular Arrhythmia
Patient was taking Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), contraindication to medical treatment, ischaemic cardiomyopathy, ventricular arrhythmia on May 19, 2008 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 182.0 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Tambocor dosage: 1po Q12 Hours Every 12 Hours Po. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), IBUROFEN (View Iburofen Review and Iburofen Label ).

5506415-2 |
Adverse event was reported on Nov 01, 2007 by a Male patient taking Tambocor (View Usage) (Dosage: 150mg Bid Po) was diagnosed with heart rate irregular and. Location: UNITED STATES , 45 years of age, weighting 190.0 lb, .

5409379-5 | Dyspepsia, Feeling Abnormal, Hyperhidrosis, Pruritus
on Aug 07, 2007 Female patient from UNITED STATES , 62 years of age, weighting 148.0 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: dyspepsia, feeling abnormal, hyperhidrosis, pruritus. Tambocor dosage: 1 Tablet Twice Daily By Mouth. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ).

5293973-9 | Pain, Pleural Effusion, Pneumonitis, Pyrexia
on Mar 22, 2007 Female patient from UNITED STATES , 70 years of age, weighting 135.0 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?), cardiac arrest (What is cardiac arrest?) and was treated with Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: pain (What is pain?), pleural effusion, pneumonitis, pyrexia. Tambocor dosage: 50mg - Bid - Po. During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ), EYE DROPS (View Eye Drops Review and Eye Drops Label ). Patient was hospitalized.

5234333-6 | Asthenia, Balance Disorder, Diaphragm Muscle Weakness, Gait Disturbance, Hypoxia, Muscular Weakness, Ventricular Hypertrophy
Patient was taking Tambocor (View Usage). Patient had the following side effects: asthenia, balance disorder, diaphragm muscle weakness, gait disturbance, hypoxia, muscular weakness, ventricular hypertrophy on Jan 31, 2007 from UNITED STATES Additional patient health information: Male patient , 49 years of age, weighting 273.4 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Tambocor dosage: 50 Mg, 2 In 1 Day (s), Oral; 100 Mg, 2 In 1 Day (s)), Oral. During the same period patient was treated with CARDIZEM (View Cardizem Review and Cardizem Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FLOMAX (View Flomax Review and Flomax Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), CLONAPIN (View Clonapin Review and Clonapin Label ). Patient was hospitalized.

5179047-6 | Cardiac Failure, Fall, Gait Disturbance, Polyneuropathy
Adverse event was reported on Nov 29, 2006 by a Male patient taking Tambocor (View Usage) (Dosage: 200 Mg (100 Mg, 2 In 1 Day (s), Oral) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: BELGIUM , 90 years of age, After Tambocor was administered, patient had the following side effects: cardiac failure, fall (What is fall?), gait disturbance, polyneuropathy. During the same period patient was treated with ASAFLOW (View Asaflow Review and Asaflow Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ).

5126407-5 | Fall, Injury, Myalgia, Neuropathy Peripheral
on Apr 03, 2006 Male patient from UNITED STATES , 52 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), hypertension and was treated with Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), injury, myalgia, neuropathy peripheral. Tambocor dosage: (50 Mg,2 In 1 Day(s)),oral. During the same period patient was treated with HYZAAR (Oral) (View Hyzaar Review and Hyzaar Label ), DIGITEK (TABLETS) (Oral) (View Digitek (tablets) Review and Digitek (tablets) Label ), CARDIZEM (Oral) (View Cardizem Review and Cardizem Label ).

5126406-3 | Arteriogram Coronary Abnormal, Chest Pain, Heart Rate Increased
on Feb 02, 2006 Male patient from UNITED STATES , 74 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). Patient had the following side effects: arteriogram coronary abnormal, chest pain (What is chest pain?), heart rate increased. Tambocor dosage: (150 Mg,2 In 1 Day(s)),oral. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

5126404-X | Cardiomegaly, Fatigue, Hepatic Enzyme Increased, Hepatic Pain, Hypoaesthesia, Oedema Peripheral, Vitreous Floaters
Patient was taking Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: cardiomegaly, fatigue, hepatic enzyme increased, hepatic pain, hypoaesthesia, oedema peripheral, vitreous floaters on Jul 29, 2005 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Tambocor dosage: (100 Mg,2 In 1 Day(s)),oral. During the same period patient was treated with VERELAN (View Verelan Review and Verelan Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ). Patient was hospitalized.

5090892-8 | Ageusia, Parosmia
Adverse event was reported on Aug 07, 2006 by a Female patient taking Tambocor (View Usage) (Dosage: 200 Mg (100 Mg, 2 In 1 Day (s)) Oral) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: GERMANY , 64 years of age, Patient experienced the following unwanted or unexpected effects: ageusia, parosmia. During the same period patient was treated with PANTOZOL (View Pantozol Review and Pantozol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5077825-5 | Arrhythmia, Atrial Fibrillation, Claustrophobia, Heart Rate Decreased, Hypotension
on Jul 24, 2006 Male patient from UNITED STATES , 64 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), tachycardia and was treated with Tambocor (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), claustrophobia, heart rate decreased, hypotension. Tambocor dosage: See Image, Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

5059428-1 | Cardiac Failure, Haemoptysis, Interstitial Lung Disease, Lung Disorder, Pulmonary Congestion
on Jul 05, 2006 Male patient from JAPAN , 70 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: cardiac failure, haemoptysis, interstitial lung disease, lung disorder, pulmonary congestion. Tambocor dosage: 100 Mg, Oral. During the same period patient was treated with BEPRICOR (100 Mg, Oral) (View Bepricor Review and Bepricor Label ), ARTIST (5 Mg; Oral) (View Artist Review and Artist Label ), MAINTATE (View Maintate Review and Maintate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5054133-X | Lung Infiltration, Pleural Effusion, Pneumonia
Patient was taking Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: lung infiltration, pleural effusion, pneumonia (What is pneumonia?) on Jul 03, 2006 from SWEDEN Additional patient health information: Male patient , 70 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Tambocor dosage: 200 Mg (100 Mg, 2 In 1 Day (s)) Oral. During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

5033241-3 | Cardiac Failure, Haemoptysis, Interstitial Lung Disease
Adverse event was reported on Jun 09, 2006 by a Male patient taking Tambocor (View Usage) (Dosage: Oral) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: JAPAN , 70 years of age, Patient had the following side effects: cardiac failure, haemoptysis, interstitial lung disease. During the same period patient was treated with BEPRICOR (Oral) (View Bepricor Review and Bepricor Label ), ARTIST (View Artist Review and Artist Label ), MAINTATE (View Maintate Review and Maintate Label ).

5026878-9 | Arrhythmia, Incorrect Dose Administered, Suicide Attempt
on May 30, 2006 Female patient from JAPAN , 60 years of age, was diagnosed with suicide attempt and was treated with Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), incorrect dose administered, suicide attempt. Tambocor dosage: 2150 Mg (1 Total) Oral. During the same period patient was treated with ARTIST (Oral) (View Artist Review and Artist Label ), GASTER D (View Gaster D Review and Gaster D Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIGMART (View Sigmart Review and Sigmart Label ), BAYCARON (View Baycaron Review and Baycaron Label ).

5016914-8 | Aphasia, Dysgraphia, Memory Impairment
on May 11, 2006 Female patient from NETHERLANDS , 46 years of age, was diagnosed with arrhythmia (What is arrhythmia?) and was treated with Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), dysgraphia, memory impairment. Tambocor dosage: 100 Mg (100 Mg, 1 In 1 Day(s)) Oral. During the same period patient was treated with ACETOSAL (View Acetosal Review and Acetosal Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).

5006916-X | Cardiac Failure, Chest X-ray Abnormal, Haemoglobin Decreased, High Density Lipoprotein Decreased, Low Density Lipoprotein Increased, Malaise, Overdose, Pacing Threshold Increased, Pleural Effusion
Patient was taking Tambocor (View Usage). Patient had the following side effects: cardiac failure, chest x-ray abnormal, haemoglobin decreased, high density lipoprotein decreased, low density lipoprotein increased, malaise, overdose, pacing threshold increased, pleural effusion on May 02, 2006 from FINLAND Additional patient health information: Female patient , 85 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Tambocor dosage: 100-200 Mg Daily As Required (100 Mg, 1-2 Tablets) Daily Oral. During the same period patient was treated with COROLIN (View Corolin Review and Corolin Label ), EMCONCOR (View Emconcor Review and Emconcor Label ). Patient was hospitalized.

4919312-8 | Arteriogram Coronary Abnormal, Chest Pain, Coronary Artery Occlusion, Heart Rate Increased
Adverse event was reported on Feb 02, 2006 by a Male patient taking Tambocor (View Usage) (Dosage: 150 Mg, 2 In 1 Day(s), Oral) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 74 years of age, After Tambocor was administered, patient had the following side effects: arteriogram coronary abnormal, chest pain (What is chest pain?), coronary artery occlusion, heart rate increased. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

4907264-6 | Coronary Artery Occlusion, Heart Rate Increased
on Feb 02, 2006 Male patient from UNITED STATES , 74 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery occlusion, heart rate increased. Tambocor dosage: (150 Mg, 2 In 1 Day(s)), Oral. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

4804514-1 | Anxiety, Condition Aggravated, Dyspnoea, Heart Rate Increased
on Oct 06, 2005 Female patient from GERMANY , 79 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). Patient had the following side effects: anxiety (What is anxiety?), condition aggravated, dyspnoea, heart rate increased. Tambocor dosage: 200 Mg (100 Mg, 2 In 1 Day (s) ) Oral. During the same period patient was treated with LANITOP (View Lanitop Review and Lanitop Label ). Patient was hospitalized.

4801179-X | Anxiety, Condition Aggravated, Dyspnoea, Heart Rate Increased
Patient was taking Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: anxiety (What is anxiety?), condition aggravated, dyspnoea, heart rate increased on Sep 26, 2005 from GERMANY Additional patient health information: Female patient , 79 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Tambocor dosage: 200 Mg (10 Mg, 2 In 1 Da (s)), Oral. During the same period patient was treated with LANITOP (View Lanitop Review and Lanitop Label ). Patient was hospitalized.

4766499-6 | Atrial Fibrillation, Blood Folate Decreased, Blood Lactate Dehydrogenase Increased, Deep Vein Thrombosis, Depression, Haemolytic Anaemia, No Therapeutic Response, Polyneuropathy
Adverse event was reported on Aug 23, 2005 by a Male patient taking Tambocor (View Usage) (Dosage: (150 Mg,) Oral) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: SWEDEN , 65 years of age, Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), blood folate decreased, blood lactate dehydrogenase increased, deep vein thrombosis (What is deep vein thrombosis?), depression (What is depression?), haemolytic anaemia, no therapeutic response, polyneuropathy. During the same period patient was treated with WARAN (View Waran Review and Waran Label ).

4760486-X | Asthenia, Chest Pain, Dyspnoea, Myocardial Infarction
on Sep 22, 2004 Female patient from UNITED STATES , 79 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). Patient had the following side effects: asthenia, chest pain (What is chest pain?), dyspnoea, myocardial infarction. Tambocor dosage: (100 Mg,2 In 1 Day(s)),oral. During the same period patient was treated with COREG (View Coreg Review and Coreg Label ). Patient was hospitalized.

4757826-4 | Haemolysis, Muscular Weakness, Polyneuropathy, Tremor
on Aug 18, 2005 Male patient from SWEDEN , 65 years of age, was diagnosed with tachycardia and was treated with Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: haemolysis, muscular weakness, polyneuropathy, tremor. Tambocor dosage: Oral.

4751060-X | Haematochezia, Hypersensitivity, Petechiae, Thrombocytopenia
Patient was taking Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: haematochezia, hypersensitivity, petechiae, thrombocytopenia on Dec 23, 2004 from GERMANY Additional patient health information: Male patient , 68 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Tambocor dosage: 100 Mg (50 Mg, 2 1 Day (s)) Oral. During the same period patient was treated with LIQUEMIN (HEPARINUM) (See Image) (View Liquemin (heparinum) Review and Liquemin (heparinum) Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), ACERCOMP (LISINOPRIL) (View Acercomp (lisinopril) Review and Acercomp (lisinopril) Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), SYMBICORT (BUDESONID) (View Symbicort (budesonid) Review and Symbicort (budesonid) Label ), ACERCOMP (HYDROCHLOROTHIAZID) (View Acercomp (hydrochlorothiazid) Review and Acercomp (hydrochlorothiazid) Label ).

4746703-0 | Pacing Threshold Decreased, Renal Failure Acute, Supraventricular Tachycardia
Adverse event was reported on Aug 04, 2005 by a Female patient taking Tambocor (View Usage) (Dosage: 100 Mg (100 Mg, 1 In 1 Day(s)) was diagnosed with tachycardia and. Location: JAPAN , 87 years of age, Patient had the following side effects: pacing threshold decreased, renal failure acute, supraventricular tachycardia. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), AMLODIN (View Amlodin Review and Amlodin Label ), PAXIL (View Paxil Review and Paxil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIOVAN (View Diovan Review and Diovan Label ), SINGULAIR (View Singulair Review and Singulair Label ).

4743439-7 | Atrial Fibrillation, Cardiac Ventricular Disorder, Cerebral Infarction, Electrocardiogram Qt Prolonged, Loss Of Consciousness, Ventricular Tachycardia
on Aug 03, 2005 Male patient from JAPAN , 68 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac ventricular disorder, cerebral infarction, electrocardiogram qt prolonged, loss of consciousness, ventricular tachycardia. Tambocor dosage: 400 Mg (200 Mg, 2 In 1 Day(s)) Oral. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

4737022-7 | Pacing Threshold Decreased, Renal Failure Acute, Supraventricular Tachycardia
on Jul 27, 2005 Female patient from JAPAN , 87 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: pacing threshold decreased, renal failure acute, supraventricular tachycardia. Tambocor dosage: 100 Mg (100 Mg, 1 In 1 Day(s)). During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), AMLODIN (View Amlodin Review and Amlodin Label ), PAXIL (View Paxil Review and Paxil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIOVAN (View Diovan Review and Diovan Label ), SINGULAIR (View Singulair Review and Singulair Label ).

4736729-5 | Abdominal Pain, Atrial Fibrillation, Cardiomegaly, Chest Pain, Disease Recurrence, Fatigue, Gastric Disorder, Hepatic Enzyme Increased
Patient was taking Tambocor (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), atrial fibrillation (What is atrial fibrillation?), cardiomegaly, chest pain (What is chest pain?), disease recurrence, fatigue, gastric disorder, hepatic enzyme increased on Jul 29, 2005 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Tambocor dosage: See Image. During the same period patient was treated with VERELAN (View Verelan Review and Verelan Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ). Patient was hospitalized.

4736459-X | Pacing Threshold Decreased, Renal Failure Acute, Supraventricular Tachycardia
Adverse event was reported on Jul 25, 2005 by a Female patient taking Tambocor (View Usage) (Dosage: 100 Mg (100 Mg, 1 In 1 Day(s)) was diagnosed with atrial fibrillation (What is atrial fibrillation?), tachycardia and. Location: JAPAN , 87 years of age, After Tambocor was administered, patient had the following side effects: pacing threshold decreased, renal failure acute, supraventricular tachycardia. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), AMLODIN (View Amlodin Review and Amlodin Label ), PAXIL (View Paxil Review and Paxil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIOVAN (View Diovan Review and Diovan Label ), SINGULAIR (View Singulair Review and Singulair Label ).

4733474-7 | Atrial Fibrillation, Cardiac Disorder, Electrocardiogram Qt Corrected Interval Prolonged, Electrocardiogram Qt Prolonged, Loss Of Consciousness, Negative Cardiac Inotropic Effect, Ventricular Tachycardia
on Jul 22, 2005 Male patient from JAPAN , 68 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cardiac disorder, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, loss of consciousness, negative cardiac inotropic effect, ventricular tachycardia. Tambocor dosage: 400 Mg (200 Mg, 2 In 1 D(s)), Oral. Patient was hospitalized.

4719564-3 | Hypotension, Hypotonia, Malaise, Nodal Arrhythmia, Pallor
on Jul 01, 2005 Male patient from SWITZERLAND , 72 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), hypertension and was treated with Tambocor (View Usage). Patient had the following side effects: hypotension, hypotonia, malaise, nodal arrhythmia, pallor. Tambocor dosage: Oral. During the same period patient was treated with SOTALOL HCL (Oral) (View Sotalol Hcl Review and Sotalol Hcl Label ), COZAAR (View Cozaar Review and Cozaar Label ), EUTHYROX (View Euthyrox Review and Euthyrox Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

4717101-0 | Bradycardia, Hypotension, Malaise, Pallor
Patient was taking Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: bradycardia, hypotension, malaise, pallor on Jul 01, 2005 from SWITZERLAND Additional patient health information: Male patient , 72 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Tambocor dosage: . During the same period patient was treated with SOTALEX (View Sotalex Review and Sotalex Label ), COZAAR (View Cozaar Review and Cozaar Label ), EUTHYROX (View Euthyrox Review and Euthyrox Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

4713485-8 | Bradycardia, Hypotension, Hypotonia, Malaise, Pallor
Adverse event was reported on Jul 01, 2005 by a Male patient taking Tambocor (View Usage) (Dosage: Oral) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: SWITZERLAND , 72 years of age, Patient experienced the following unwanted or unexpected effects: bradycardia, hypotension, hypotonia, malaise, pallor. During the same period patient was treated with SOTALOL HCL (Oral) (View Sotalol Hcl Review and Sotalol Hcl Label ), COZAAR (View Cozaar Review and Cozaar Label ), EUTHYROX (View Euthyrox Review and Euthyrox Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

4708448-2 | Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Atrial Fibrillation, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Electrocardiogram Qrs Complex Prolonged, Liver Disorder
on Jun 21, 2005 Female patient from JAPAN , 77 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). Patient had the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), blood creatinine increased, blood lactate dehydrogenase increased, electrocardiogram qrs complex prolonged, liver disorder. Tambocor dosage: 1 In 1 Day(s). During the same period patient was treated with ATENOLOL (1 In 1;) (View Atenolol Review and Atenolol Label ), PIRMENOL HYDROCHLORIDE (1 In 1 Day) (View Pirmenol Hydrochloride Review and Pirmenol Hydrochloride Label ). Patient was hospitalized.

4695175-3 | Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Atrial Fibrillation, Blood Lactate Dehydrogenase Increased, Liver Disorder, Pyrexia, Shock
on Jun 10, 2005 Female patient from , 77 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), blood lactate dehydrogenase increased, liver disorder, pyrexia, shock. Tambocor dosage: (1 In 1 Day(s)) Oral. During the same period patient was treated with ATENOLOL (1 In 1 Day(s))) (View Atenolol Review and Atenolol Label ), PIRMENOL HYDROCHLORIDE ((1 In 1 Day(s))) (View Pirmenol Hydrochloride Review and Pirmenol Hydrochloride Label ). Patient was hospitalized.

4643207-0 | Dehydration, Diarrhoea, Renal Failure, Vomiting
Patient was taking Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, renal failure, vomiting on Apr 13, 2005 from Additional patient health information: Male patient , 66 years of age, . Tambocor dosage: 300 Mg (150 Mg, 2 In 1 Day(s)), Oral. Patient was hospitalized.

4588776-4 | Rash Morbilliform, Skin Reaction, Urticaria
Adverse event was reported on Feb 14, 2005 by a Female patient taking Tambocor (View Usage) (Dosage: Takes 1 Tab Twice Daily) was diagnosed with supraventricular tachycardia and. Location: , 57 years of age, Patient had the following side effects: rash morbilliform, skin reaction, urticaria. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ).

4565552-X | Atrial Fibrillation, Heart Rate Decreased
on Jan 25, 2005 Male patient from , weighting 167.0 lb, was diagnosed with ventricular tachycardia and was treated with Tambocor (View Usage). After Tambocor was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), heart rate decreased. Tambocor dosage: Daily. Patient was hospitalized and became disabled.

4544888-2 | Haematochezia, Hypersensitivity, Petechiae, Thrombocytopenia
on Dec 27, 2004 Male patient from , 68 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Tambocor (View Usage). Patient experienced the following unwanted or unexpected effects: haematochezia, hypersensitivity, petechiae, thrombocytopenia. Tambocor dosage: 100 Mg (50 Mg, 2 In 1 Day(s)) Oral. During the same period patient was treated with LIQUEMIN (HEPARINUM) (25.000 Ie (25.000 Ie Day) (3 X 7.500 Ie) Intravenous) (View Liquemin (heparinum) Review and Liquemin (heparinum) Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), ACERCOMP (LISINOPRIL/ HYDROCHLOROZIDE) (View Acercomp (lisinopril/ Hydrochlorozide) Review and Acercomp (lisinopril/ Hydrochlorozide) Label ), ISOPTIN (VERAPAMIL) (View Isoptin (verapamil) Review and Isoptin (verapamil) Label ), SYMBICORT (BUDESONID) (View Symbicort (budesonid) Review and Symbicort (budesonid) Label ), ................. (View ................. Review and ................. Label ).